Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
CUF Porto Hospital · Université Paris-Sud · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
829
total citations
- FWCI
- 42.82
- Percentile
- 100%
- References
- 61
Citations per year
Authors
12- DADirk Arnold
CUF Porto Hospital
- BLB. Lueza
Université Paris-Sud, Inserm, Université Paris-Saclay, La Ligue Contre le Cancer, Centre de recherche en Epidémiologie et Santé des Populations
- JDJean-Yves Douillard
European Society for Medical Oncology
- MPMarc Peeters
Antwerp University Hospital
- HLHeinz‐Josef Lenz
USC Norris Comprehensive Cancer Center
Topics & keywords
Topics
Keywords
- Medicine
- Internal medicine
- KRAS
- Colorectal cancer
- Hazard ratio
- Oncology
- Bevacizumab
- Chemotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.